Company / Working Capital per Share
Trevi Therapeutics, Inc. Working Capital per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$0.97
FY2024
5-year range
$0.83 / $2.25
FY2020-FY2024
Trend
+17.6%
vs FY2023
Sector context
#179 of 210
Health Care
What the data says
Trevi Therapeutics, Inc.'s working capital per share of $0.97 is lower than 85% of companies in the Health Care sector (FY2024). Working Capital per Share has fluctuated over the past 7 years, ranging from $0.83 in FY2023 to $14.05 in FY2018.
Based on SEC 10-K filings.
0.97 in FY2024 with a 5-year CAGR of -26.8%.
Declined from $1.69 to $0.97 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -4.2%
- 5-Year CAGR
- -26.8%
- 10-Year CAGR
- -
Sector benchmark
-99.3% below sector average
Key checks
Key Insights
- In FY2024, working capital per share increased 17.6% year-over-year.
- Ranks #179 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2018.
- Lowest working capital per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.97 | +17.6% |
| FY2023 | $0.83 | -51.2% |
| FY2022 | $1.69 | +53.2% |
| FY2021 | $1.10 | -51.0% |
| FY2020 | $2.25 | -51.3% |
| FY2019 | $4.63 | -67.0% |
| FY2018 | $14.05 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026